S&P 500 Futures
(-0.11%) 5 141.50 points
Dow Jones Futures
(-0.07%) 38 532 points
Nasdaq Futures
(-0.04%) 17 896 points
Oil
(0.08%) $82.70
Gas
(2.51%) $2.08
Gold
(-1.28%) $2 327.60
Silver
(-2.57%) $26.95
Platinum
(-1.00%) $951.90
USD/EUR
(0.18%) $0.934
USD/NOK
(0.36%) $11.02
USD/GBP
(0.19%) $0.798
USD/RUB
(-0.10%) $93.21

Actualizaciones en tiempo real para PuraPharm Corp Ltd [1498.HK]

Bolsa: HKSE Sector: Pharmaceuticals Industria: Drug Manufacturers—Specialty & Generic
Última actualización30 abr 2024 @ 03:15

4.11% HKD 0.760

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 03:15):

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally...

Stats
Volumen de hoy 13 500.00
Volumen promedio 53 974.00
Capitalización de mercado 300.24M
EPS HKD0 ( 2024-03-28 )
Last Dividend HKD0.0191 ( 2017-05-31 )
Next Dividend HKD0 ( N/A )
P/E -2.81
ATR14 HKD0 (0.00%)

PuraPharm Corp Ltd Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PuraPharm Corp Ltd Finanzas

Annual 2023
Ingresos: HKD406.86M
Beneficio Bruto: HKD214.85M (52.81 %)
EPS: HKD-0.270
FY 2023
Ingresos: HKD406.86M
Beneficio Bruto: HKD214.85M (52.81 %)
EPS: HKD-0.270
FY 2022
Ingresos: HKD448.07M
Beneficio Bruto: HKD260.59M (58.16 %)
EPS: HKD-0.300
FY 2021
Ingresos: HKD659.59M
Beneficio Bruto: HKD423.35M (64.18 %)
EPS: HKD-0.329

Financial Reports:

No articles found.

PuraPharm Corp Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

PuraPharm Corp Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0.0346 - low (50.00%) | Divividend Growth Potential Score: 1.356 - No dividend growth expected in the near future
Information
First Dividend HKD0.0840 2016-05-19
Last Dividend HKD0.0191 2017-05-31
Next Dividend HKD0 N/A
Payout Date 2017-06-23
Next Payout Date N/A
# dividends 2 --
Total Paid Out HKD0.103 --
Avg. Dividend % Per Year 0.00% --
Score 0.73 --
Div. Sustainability Score 0.0346
Div.Growth Potential Score 1.356
Div. Directional Score 0.695 --
Next Divdend (Est)
(2025-03-31)
HKD0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.73
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
2327.HK Ex Dividend Junior 2023-08-03 Sporadic 0 0.00%
1290.HK Ex Dividend Junior 2023-06-14 Sporadic 0 0.00%
0363.HK Ex Dividend Knight 2023-06-01 Annually 0 0.00%
6117.HK Ex Dividend Junior 2023-05-22 Sporadic 0 0.00%
1857.HK Ex Dividend Junior 2023-08-23 Semi-Annually 0 0.00%
0881.HK Ex Dividend Junior 2023-06-23 Annually 0 0.00%
0026.HK Ex Dividend Junior 2023-10-03 Semi-Annually 0 0.00%
2669.HK Ex Dividend Knight 2023-06-23 Semi-Annually 0 0.00%
1428.HK Ex Dividend Knight 2023-08-23 Annually 0 0.00%
0518.HK Ex Dividend Junior 2023-09-01 Sporadic 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.2611.500-5.21-7.82[0 - 0.5]
returnOnAssetsTTM-0.1261.200-4.19-5.03[0 - 0.3]
returnOnEquityTTM-0.5741.500-7.49-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM0.6120.800-1.939-1.552[1 - 3]
quickRatioTTM0.2250.800-3.38-2.70[0.8 - 2.5]
cashRatioTTM0.08271.500-0.652-0.978[0.2 - 2]
debtRatioTTM0.478-1.5002.04-3.06[0 - 0.6]
interestCoverageTTM-1.7981.000-1.777-1.777[3 - 30]
operatingCashFlowPerShareTTM0.1372.009.9510.00[0 - 30]
freeCashFlowPerShareTTM0.08182.009.9610.00[0 - 20]
debtEquityRatioTTM2.63-1.50010.00-10.00[0 - 2.5]
grossProfitMarginTTM0.5281.0004.534.53[0.2 - 0.8]
operatingProfitMarginTTM-0.1211.000-4.42-4.42[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1341.000-0.367-0.367[0.2 - 2]
assetTurnoverTTM0.4820.800-0.119-0.0956[0.5 - 2]
Total Score0.0346

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-2.721.000-0.3760[1 - 100]
returnOnEquityTTM-0.5742.50-4.81-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.08182.009.9710.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.1372.009.9510.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.02461.500-3.500[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1331.0009.180[0.1 - 0.5]
Total Score1.356

PuraPharm Corp Ltd

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico